About Us / Our History
MOPSON Pharmaceutical Limited develops, produces, and markets drugs licensed for use as medications. MOPSON pharmaceutical limited are makers of both ethical and generic medications The company’s products are all registered with the National Agency for Food and Drugs Administration Control (NAFDAC) in compliance with the statutory regulation.
MOPSON Pharmaceutical Limited has been in the business of manufacturing and supply of medicines since 1977. The company has been the preferred supplier of most of the pharmaceutical requirements of government institutions like Government Hospitals, University Teaching Hospitals, industrial clinics, private hospitals, and clinics in Nigeria.
Today, the company is reputed for the quality of its pharmaceutical products with over 50 products developed by the in-house research and development division of the firm.
Mopson Pharmaceutical Limited is a NIS ISO 9001:2008 certified company. It is a limited liability company incorporated under the Nigerian Companies’ Act. It started operations in 1977.
All Mopson’s products are award-winning and were developed by the company’s research and Development Laboratory. For example, Neofylin cough syrup was adjudged as Africa’s best cough mixture of the year 2006 and Asmalyn syrup won the best Asthma management award in 2012.
Thus, his products have been tagged “Products of excellence” nationally and internationally. In 1992, the company started a research project to develop stable and potent Vitamin C syrup. Two institutions, the University of Lagos and the University of Ibadan were involved under the guidance of Professor Olaniyi of the University of Ibadan and Professor Fola Tayo of the University of Lagos. The project was successful and this led to the birth of Ascorbion C 300 which today is the most stable, most potent, and most affordable Vitamin C syrup in the market with less than 5% loss after ten years.
He is the recipient of several commendations and awards for his industrial and charitable prowess. In 1998, he received the “ECOWAS Gold Award” in recognition of his distinguished entrepreneurial endeavor. The same year, he was recognized as “Man of the Year” by the Guardian Newspaper. He also received from the Rotary Club an award for “Industrialist of the Year” in 1998. In 1999, he received the “Prestigious Leadership Award of Excellence” from the Science Teachers Association of Nigeria and the “Eminent Persons Award” from the Nigerian Associations of Industrial Pharmacists. In 2002, he became a fellow of the prestigious West African Postgraduate College of Pharmacy. He is also a fellow of the Pharmaceutical Society of Nigeria. On the 4th July 2013, he became a recipient of an honorary Doctor of Business Administration degree (DBA) from the reputable Commonwealth University. Dr. Michael Oyebanjo Paul, Chairman / Managing Director, Mopson Pharmaceutical Ltd, is a devout Christian and a philanthropist. He is married and blessed with children.
Mopson Pharmaceutical Limited has been in the business of manufacturing and supply of medicines since 1977. The company has been the preferred supplier of most of the pharmaceutical requirements of government institutions like Government Hospitals, University Teaching Hospitals, industrial clinics, private hospitals, and clinics in Nigeria. Mopson Pharmaceutical Limited develops, produces, and markets drugs licensed for use as medications. Mopson pharmaceutical limited are makers of both ethical and generic medications. The company’s products are all registered with the National Agency for Food and Drugs Administration (NAFDAC) in compliance with the statutory regulation. Today, the company is reputed for the quality of its pharmaceutical products with over 50 products developed by the in-house research and development division of the firm.
